XBI
ETF Biotechnology NYSEARCA

SPDR S&P Biotech ETF

$150.97
+3.94 (+2.68%)
Fund Overview by SPDR (State Street)

Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.

AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$147.06
Prev Close$147.03
Day Range$147.06 — $151.78
52W Range$66.66 — $132.09
52-Week Range
$66.66 $132.09
From 52W High
14.3%
From 52W Low
+126.5%
Investment Calculator

See how much dividend income XBI could generate based on its current price of $150.97 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.

$
Shares Purchased66
Amount Invested$9,964.02
Annual Income$9.96
Monthly Income$0.83

Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.

Biotechnology ETF Comparison
ETF Price Change Expense AUM Holdings Yield
XBI
SPDR S&P Biotech ETF
 $150.97 +2.68% 0.35% $6.5B 145 0.1%
IBB
iShares Biotechnology ETF
 $182.70 +2.59% 0.44% $7.8B 224 0.2%
ARKG
ARK Genomic Revolution ETF
 $39.01 +8.33% 0.75% $1.8B 35 0.0%
Top Biotechnology Stocks View all →
Stock Price Change Market Cap
ABBV
Abbvie Inc
 $234.89 +0.06% 382.49B
AMGN
Amgen Inc
 $351.43 +1.27% 182.21B
GILD
Gilead Sciences Inc
 $125.16 +0.09% 153.66B
VRTX
Vertex Pharmaceuticals Inc
 $475.20 +1.45% 114.63B
REGN
Regeneron Pharmaceuticals
 $623.43 +0.87% 63.95B
ALNY
Alnylam Pharmaceuticals Inc
 $294.06 +2.04% 37.13B
RVMD
Revolution Medicines Inc
 $169.77 +0.15% 34.65B
NTRA
Natera Inc
 $259.97 +10.74% 33.14B
BIIB
Biogen Inc
 $199.59 +1.22% 29.02B
MRNA
Moderna Inc
 $60.42 -0.95% 25.38B
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
What are the alternatives to XBI?
Other biotechnology ETFs include IBB, ARKG. Each offers different expense ratios, weighting methodologies, and number of holdings. Compare them in the ETF comparison table above to find the best fit for your portfolio.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
View List →

Last updated: Jun 24, 2026 at 6:30 PM ET